Skip to Content

New Drug Approvals Archive - November 2007

November 2007

November 6

Abilify (aripiprazole)

Patient Population Altered: October 29, 2007

November 9

Crestor (rosuvastatin calcium)

New Indication Approved: November 8, 2007

November 14

Mircera (epoetin beta-methoxy polyethylene glycol) Injection

Date of Approval: November 14, 2007
Company: Roche
Treatment for: Anemia Associated with Chronic Renal Failure

Mircera (epoetin beta-methoxy polyethylene glycol) is an erythropoiesis-stimulating agent indicated for the treatment of anemia associated with chronic renal failure.

Mircera (epoetin beta-methoxy polyethylene glycol) FDA Approval History

November 16

Seroquel XR (quetiapine)

New Indication Approved: November 15, 2007

Seroquel XR (quetiapine) FDA Approval History

November 20

Abilify (aripiprazole)

New Indication Approved: November 16, 2007

November 30

Cymbalta (duloxetine)

New Indication Approved: November 28, 2007

Cymbalta (duloxetine) FDA Approval History

November 29

Triesence (triamcinolone acetonide) Injectable Suspension

Date of Approval: November 29, 2007
Company: Alcon, Inc.
Treatment for: Temporal Arteritis, Uveitis

Triesence (triamcinolone acetonide) is a synthetic corticosteroid indicated for visualization during vitrectomy and treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Triesence (triamcinolone acetonide) FDA Approval History

New Drug Approvals Archive